Skip to main content

Complications of Peptic Ulcer Disease!

 COMPLICATIONS OF PEPTIC ULCER DISEASE

  1. Bleeding peptic ulcer
  2. Pyloric stenosis
  3. Zollinger-Ellison Disease
  4. Stress Ulcers


Bleeding peptic ulcer:

  • Peptic ulcer is the most common cause of non-variceal upper gastro-intestinal bleeding.
  • Most patients with bleeding peptic ulcer are clinically stable and stop bleeding without any intervention, whereas other outcomes include re-bleeding and mortality.
  • Endoscopy allows identification of the severity of disease.
  • Endoscopic hemostatic therapy which is successful in reducing mortality.
  • A number of pharmacological agents have been used for endoscopic injection therapy such as 1:10000 adrenaline (epinephrine), human thrombin and fibrin glue.
  • Mechanical endoscopic treatment options include Thermocoagulation using a heater probe or endoscopic clipping.
  • Combination therapies are superior to monotherapy and a combination of adrenaline 1:10000 with either thermal or mechanical treatment is recommended (SIGN,2008).



Pyloric Stenosis:

Malignancy is the most common cause of gastric outlet obstruction.
Peptic ulcer disease is the underlying cause in about 10% of cases.
Conventional treatment with acid-suppressive therapy may also help.
If medical therapy fails to relieve the obstruction, Endoscopic balloon dilation or surgery may be required.


Zollinger-Ellison Syndrome:

  • This is a rare syndrome that consists of a triad of non-beta cell tumors of the pancreas that contain and release gastrin, gastric acid hypersecretion and severe ulcer disease.
  • Extra-pancreatic gastrinomas are also common and may be frequently found in the duodenal wall.
  • A proportion of these patients have tumors of the pituitary gland and parathyroid gland.
  • Patients with idiopathic peptic ulcer disease should be investigated for Zollimger-Ellison Syndrome.
  • Medical management includes; greater than standard doses of Proton Pump Inhibitors. The somatostatin analogue OCTREOTIDE is also effective but has no clear advantage over PPIs.


Stress Ulcers:

  • Sever physiological stress such as Head Injury, Spinal cord injury, Burns, Multiple traumas or Sepsis may induce superficial mucosa erosions or gastroduodenal ulcerations. These may lead to hemorrhage or perforation.
  • Diminished blood flow to the gastric mucosa, decreased cell renewal, diminished prostaglandin production and hypertension are involved in causing stress ulceration.
  • Management involves: Intravenous acid-suppression therapy, Histamine H-receptor antagonists, PPIs and Nasogastric tube administration of SUCRALFATE (4-6g daily in divided doses) have been used to prevent stress ulceration in the intensive care unit until patient tolerates enteral feeding.
Most commonly used regimens are: IV Ranitidine 50mg every 8hr reducing to 25mg in severe renal impairment.
  • Patients at Mechanical ventilation and the presence of coagulopathies are at higher risks of stress-related mucosal bleeding and may require prophylactic treatment.


Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...
Post a Comment
Read more

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more

Myocardial Infarction- Etiology, Pathogenesis, Clinical Diagnosis and Management!

MYOCARDIAL INFARCTION Definition: Myocardial Infarction is defined as " a diseased condition which is caused by reduced blood flow to the coronary artery due to atherosclerosis and occlusion of artery by embolus or thrombus." Myocardial Infarction (or Heart attack) is the irreversible damage of myocardial tissue due to prolonged ischemia or hypoxia. Universally accepted definition of MI:  Evidence of myocardial necrosis in consistent with the myocardial ischemia, in which case any of the following meets the diagnosis of Myocardial Infarction. Evidence rises and/or fall of cardiac biomarkers (preferably troponin). ECG changes indicative of new ischemia (new ST-T changes or new left bundle branch block) Development of pathological Q waves. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. Etiology: Tobacco smoking Diabetes Mellitus Age Hypertension Obesity Gender Stress Drug abuse Alcohol consumption Family history of ischemic heart dise...
Post a Comment
Read more